IP Library › Granted Patent US 12,421,223
Granted Patent B2
US 12,421,223 · App. 17/292,891 · Granted Sep 23, 2025

Compounds and compositions for treating conditions associated with NLRP activity

Inventors: Shomir Ghosh (Brookline, MA); Jason Katz (Newton, MA); William Roush (Boston, MA); Hans Martin Seidel (Concord, MA); Dong-Ming Shen (Edison, NJ); Shankar Venkatraman (Lansdale, PA)
Assignee: Novartis AG
C07D417/06A61P35/00C07D401/06C07D417/12C07D417/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,421,223
App. No.
17/292,891
Granted
Sep 23, 2025
Kind
B2
Abstract

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Claims (1)

1. A compound selected from:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2021
From: GHOSH, SHOMIR; KATZ, JASON; ROUSH, WILLIAM; SEIDEL, HANS MARTIN; SHEN, DONG-MING; VENKATRAMAN, SHANKAR
To: IFM MANAGEMENT, INC.
Reel/Frame 057024/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2021
From: IFM MANAGEMENT, INC.
To: NOVARTIS INFLAMMASOME RESEARCH, INC.
Reel/Frame 057024/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2021
From: NOVARTIS INFLAMMASOME RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 057025/0001 →